Please login to the form below

Not currently logged in
Email:
Password:

New Boehringer Ingelheim facility in US

Germany-based pharmaceutical company Boehringer Ingelheim has started the construction of a new safety assessment building in the US

Boehringer Ingelheim, the German pharmaceutical company, has started building a $42.5m safety assessment facility at its campus in Danbury-Ridgefield, Connecticut, in the US.

Dr James Baxter, Boehringer Ingelheim's senior vice president for development in the US, said the 63,000sq ft building would provide a safety testing facility for the new biologic drugs that the company is developing in Connecticut and at its facilities in Laval, Canada; Vienna, Austria and Biberach, Germany. It hopes to open the new building in 2013.

The company is also proposing to build a $65m pilot plant replacement facility nearby, to synthesise and produce the active ingredients it needs for future new drugs. It has not yet secured permission to build the second facility.

However, the company has been offered seven-year tax abatement to stay in the area and when the building is finished, Boehringer Ingelheim will only pay 15 per cent of the taxes assessed on the building for seven years. After this period, it will pay full tax.

24th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics